Defining the lung cancer patient population admitted to intensive care in Australia

None listed

This study will examine the characteristics of lung cancer patients admitted to intensive care and their outcomes at 3 month post-intensive care discharge Who is it for? This is a retrospective study of adult patients 18 years or older with lung cancer who were admitted to the intensive care unit at the Sunshine Coast University Hospital with a critical illness Study details: It is intended to collect data on patient demographics (age, sex, smoking status, performance status etc.), malignancy characteristics (type of lung cancer, molecular profile, staging etc.), and patient outcomes (survival to ICU and hospital discharge, 30- and 90-day survival, anti-cancer treatment received within 90 days of ICU discharge, etc.). Patients admitted to the ICU between 01/01/2018 and 01/01/2020 will be screened for those with a diagnosis of lung cancer (pre-existing or diagnosed [suspected or confirmed] during ICU admission). These patient’s charts will then be reviewed by a Queensland Health employee to extract the relevant data. The data will then be analysed to look at relationships between patient and malignancy details and patient outcomes. This study hopes to clarify the role intensive care plays in the treatment of lung cancer patients and to help better identify those patients who will benefit from treatment in Australian intensive care units.

No related papers found yet.